The Drug and Food Administration introduced this week that it’s investigating 127 reports of seizures or other neurological issues which may be linked to the use of e-cigarettes, a figure that has expanded by almost 100 since the company first introduced its probe back in April.
The FDA stated Wednesday in an update on its investigation that the incidents spanned a period between 2010 and 2019 and included episodes of tremors or fainting, which it mentioned could be—however aren’t essentially—related to seizures. While the variety of incidents the company is looking into has widened, the FDA was careful to note that they “don’t necessarily indicate a rise in frequency or prevalence of such incidents.”
The FDA mentioned that it plans to continue releasing updates on the standing of its investigation and encouraged the public to share any experiences of “sudden health or product issues” via its online reporting portal.
“Though we still don’t have sufficient information to determine if e-cigarettes are inflicting these reported incidents, we believe it’s vital to keep the public updated on the data we’ve acquired based on the company’s initial request for reports earlier this year,” Appearing FDA Commissioner Ned Sharpless stated in a statement. “We appreciate the public response to our initial call for reports, and we strongly encourage the public to submit new or follow-up reports with as much detail as possible.”
The FDA introduced its investigation into a potential correlation between vaping and seizures earlier this year, at which time it mentioned that voluntary reports collected by poison management centers and the FDA throughout the same 10-year period turned up 35 reported cases of seizures that specifically talked about the use of e-cigarettes.